Search research articles
Contact Us
Filters
Showing results (91-100 of 131) with videos related to
Page
of 14
Sort By:
Biochemical and Biophysical Research Communications
|
September 15, 1988
Reduction to homozygosity at the SIS/PDGF-2 locus in human mesenchymal tumors
D M Shin, C Ince, M Shtalrid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1995
Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer
F V Fossella, J S Lee, D M Shin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 11, 1998
Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study
B Glisson, R Komaki, J S Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1994
Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer
F V Fossella, J S Lee, W K Murphy, et al.
Investigational New Drugs
|
June 9, 1999
Phase I study of paclitaxel administered by ten-day continuous infusion
R J Shade, K M Pisters, M H Huber, et al.
British Journal of Cancer
|
November 13, 2008
Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma
H Zhang, L Su, S Müller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2001
Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck
M R Posner, B Glisson, G Frenette, et al.
Scandinavian Journal of Immunology
|
December 7, 2007
Expression and regulation of the CC-chemokine ligand 20 during human tuberculosis
J-S Lee, J-Y Lee, J W Son, et al.
Journal of the National Cancer Institute
|
March 3, 1993
Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer
W K Murphy, F V Fossella, R J Winn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852
R Perez-Soler, N J Donato, D M Shin, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 131) with videos related to
Sort By:
Page
of 14
Biochemical and Biophysical Research Communications
|
September 15, 1988
Reduction to homozygosity at the SIS/PDGF-2 locus in human mesenchymal tumors
D M Shin, C Ince, M Shtalrid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1995
Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer
F V Fossella, J S Lee, D M Shin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 11, 1998
Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study
B Glisson, R Komaki, J S Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1994
Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer
F V Fossella, J S Lee, W K Murphy, et al.
Investigational New Drugs
|
June 9, 1999
Phase I study of paclitaxel administered by ten-day continuous infusion
R J Shade, K M Pisters, M H Huber, et al.
British Journal of Cancer
|
November 13, 2008
Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma
H Zhang, L Su, S Müller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2001
Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck
M R Posner, B Glisson, G Frenette, et al.
Scandinavian Journal of Immunology
|
December 7, 2007
Expression and regulation of the CC-chemokine ligand 20 during human tuberculosis
J-S Lee, J-Y Lee, J W Son, et al.
Journal of the National Cancer Institute
|
March 3, 1993
Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer
W K Murphy, F V Fossella, R J Winn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852
R Perez-Soler, N J Donato, D M Shin, et al.
Page
of 14